Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha1H in non-muscle invasive bladder cancer awaiting TURB
2024-514628-17-00Phase 2Completed
- Sponsor
- Hamlet BioPharma
- Start
- Jan 2025
- Modality
- Albumin → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in bladder cancer comparing Alpha1H with Placebo (2 arms). Primary endpoints: Adverse events (local and systemic), Quantification of tumor cell shedding in urine and 1 more. Started Jan 2025; status: completed.
02
Drugs
alpha1-oleate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2024-514628-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514628-17-00.